5. ACKNOWLEDGMENTS
The authors would like to thank the CFF VIP-7 team, KIFDER volunteers,
patients for participating and for their feedback and assistance in
conducting the study.
References
1. Stephenson AL, Swaleh S, Sykes J, et al. Contemporary cystic fibrosis
incidence rates in Canada and the United States. 2023;22:443-9.
2. Southern KW, Munck A, Pollitt R, et al. A survey of newborn screening
for cystic fibrosis in Europe. 2007;6:57-65.
3. Scotet V, Gutierrez H, Farrell PMJIjons. Newborn screening for CF
across the globe—Where is it worthwhile? 2020;6:18.
4. Keogh RH, Szczesniak R, Taylor-Robinson D, Bilton DJJoCF. Up-to-date
and projected estimates of survival for people with cystic fibrosis
using baseline characteristics: A longitudinal study using UK patient
registry data. 2018;17:218-27.
5. Burgel P-R, Bellis G, Olesen HV, et al. Future trends in cystic
fibrosis demography in 34 European countries. 2015;46:133-41.
6. McGarry ME, McColley SAJPp. Cystic fibrosis patients of minority race
and ethnicity less likely eligible for CFTR modulators based on CFTR
genotype. 2021;56:1496-503.
7. Colver A, Longwell SJAodic. New understanding of adolescent brain
development: relevance to transitional healthcare for young people with
long term conditions. 2013;98:902-7.
8. Aldiss S, Ellis J, Cass H, Pettigrew T, Rose L, Gibson FJJopn.
Transition from child to adult care–‘It’s Not a One-Off Event’:
Development of benchmarks to improve the experience. 2015;30:638-47.
9. Okumura MJ, Hersh AO, Hilton JF, Lotstein DSJJoah. Change in health
status and access to care in young adults with special health care
needs: results from the 2007 national survey of adult transition and
health. 2013;52:413-8.
10. Singh J, Towns S, Jayasuriya G, et al. Transition to adult care in
cystic fibrosis: The challenges and the structure. 2022;41:23-9.
11. Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis
care: a global perspective. 2020;8:65-124.
12. Goralski JL, Nasr SZ, Uluer AJPP. Overcoming barriers to a
successful transition from pediatric to adult care. 2017;52:S52-S60.
13. Genovese VV, Perceval M, Buscarlet-Jardine L, et al. Smoothing the
transition of adolescents with CF from pediatric to adult care:
Pre-transfer needs. 2021;28:257-63.
14. Brumfield K, Lansbury GJD, rehabilitation. Experiences of
adolescents with cystic fibrosis during their transition from paediatric
to adult health care: a qualitative study of young Australian adults.
2004;26:223-34.
15. Peeters MA, Sattoe JN, van Staa A, et al. Controlled evaluation of a
transition clinic for Dutch young people with cystic fibrosis.
2019;54:1811-20.
16. Chaudhry SR, Keaton M, Nasr SZJPp. Evaluation of a cystic fibrosis
transition program from pediatric to adult care. 2013;48:658-65.
17. Baker AM, Riekert KA, Sawicki GS, Eakin MNJPA, Immunology,,
Pulmonology. CF RISE: implementing a clinic-based transition program.
2015;28:250-4.
18. https://cfrise.com/cf-resources
19. https://www.kifder.org.tr/sobe
20. Bourgeois G, Magne F, Nove Josserand R, et al. A formalized
transition program for cystic fibrosis: A 10‐year retrospective analysis
of 97 patients in Lyon. 2021;56:2000-6.
21. Connett GJ, Nagra AJPRR. Ready, steady, go–Achieving successful
transition in cystic fibrosis. 2018;27:13-5.
22. Kirk SJCc, health, development. Transitions in the lives of young
people with complex healthcare needs. 2008;34:567-75.